Frontiers in Medicine

China Biotech: Feast or Famine?

Examining biotech's newest innovation engine

May 31 • Céline

CAR-T, Part 3

How Dr. Georg Schett sparked renaissance in autoimmune disease

May 24 • Céline

CAR-T, Part 2

Beyond autologous CAR-T: allogeneic, in vivo, and T-cell engagers (TCE)

May 16 • Céline

CAR-T, Part 1

Immunology Civil War, the discovery of T-cells, and their rebirth as medicines

May 9 • Céline

Obesity, Part 2

Evolution of treatments: from dark age to golden age

May 1 • Céline

Obesity, Part 1

Societal perception, recognition as a disease, and the discovery of its hormonal & genetic drivers

Apr 28 • Céline

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Biotech Readout

Frontiers in Medicine